Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Biol Chem ; 277(46): 43623-30, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12218049

ABSTRACT

In PC12 cells, a well studied model for neuronal differentiation, an elevation in the intracellular cAMP level increases cell survival, stimulates neurite outgrowth, and causes activation of extracellular signal-regulated protein kinase 1 and 2 (ERK1/2). Here we show that an increase in the intracellular cAMP concentration induces tyrosine phosphorylation of two receptor tyrosine kinases, i.e. the epidermal growth factor (EGF) receptor and the high affinity receptor for nerve growth factor (NGF), also termed Trk(A). cAMP-induced tyrosine phosphorylation of the EGF receptor is rapid and correlates with ERK1/2 activation. It occurs also in Panc-1, but not in human mesangial cells. cAMP-induced tyrosine phosphorylation of the NGF receptor is slower and correlates with Akt activation. Inhibition of EGF receptor tyrosine phosphorylation, but not of the NGF receptor, reduces cAMP-induced neurite outgrowth. Expression of dominant-negative Akt does not abolish cAMP-induced survival in serum-free media, but increases cAMP-induced ERK1/2 activation and neurite outgrowth. Together, our results demonstrate that cAMP induces dual signaling in PC12 cells: transactivation of the EGF receptor triggering the ERK1/2 pathway and neurite outgrowth; and transactivation of the NGF receptor promoting Akt activation and thereby modulating ERK1/2 activation and neurite outgrowth.


Subject(s)
Cyclic AMP/metabolism , ErbB Receptors/metabolism , MAP Kinase Signaling System , Neurons/metabolism , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/metabolism , Receptor, Nerve Growth Factor/metabolism , Transcriptional Activation , 8-Bromo Cyclic Adenosine Monophosphate/metabolism , Animals , Apoptosis , Cell Death , Cell Division , Colforsin/pharmacology , Culture Media, Serum-Free/pharmacology , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Enzyme Activation , Epidermal Growth Factor , Genes, Dominant , Immunoblotting , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/metabolism , PC12 Cells , Phosphorylation , Precipitin Tests , Protein Binding , Proto-Oncogene Proteins c-akt , Rats , Transfection
3.
Am J Physiol Gastrointest Liver Physiol ; 282(3): G450-60, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11841995

ABSTRACT

Pancreatic acinar cells depend on the integrity of the cytoskeleton for regulated secretion. Stimulation of isolated rat pancreatic acini with the secretagogue CCK serves as a model for human acute edematous pancreatitis. It induces the breakdown of the actin filament system (F-actin) with the consecutive inhibition of secretion and premature activation of digestive enzymes. However, the mechanisms that regulate F-actin breakdown are largely unknown. Plectin is a versatile cytolinker protein regulating F-actin dynamics in fibroblasts. It was recently demonstrated that plectin is a substrate of caspase 8. In pancreatic acinar cells, plectin strongly colocalizes with apical and basolateral F-actin. Supramaximal secretory stimulation of acini with CCK leads to a rapid redistribution and activation of caspase 8, followed by degradation of plectin that in turn precedes the F-actin breakdown. Inhibition of caspase 8 before CCK hyperstimulation prevents plectin cleavage, stabilizes F-actin morphology, and reverses the inhibition of secretion. Thus we propose that the caspase 8-mediated degradation of plectin represents a critical biochemical event during CCK-induced secretory blockade and cell injury.


Subject(s)
Actins/metabolism , Caspases/metabolism , Intermediate Filament Proteins/metabolism , Pancreas/metabolism , Pancreatitis/metabolism , Amylases/metabolism , Animals , Blotting, Western , Caspase 8 , Caspase 9 , Caspase Inhibitors , Caspases/pharmacology , Cholecystokinin/pharmacology , Cytoskeleton/drug effects , Enzyme Activation , Enzyme Inhibitors/pharmacology , Fluorescent Antibody Technique , Immunoblotting , Kinetics , Male , Pancreas/drug effects , Pancreas/ultrastructure , Plectin , Rats , Rats, Wistar , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...